Shalby Limited Stock Bombay S.E.

Equities

SHALBY

INE597J01018

Healthcare Facilities & Services

Market Closed - Bombay S.E. 06:00:54 2024-07-12 am EDT 5-day change 1st Jan Change
287.7 INR -2.95% Intraday chart for Shalby Limited -7.49% -4.72%
Sales 2024 9.53B 114M Sales 2025 * 10.61B 127M Capitalization 30.94B 371M
Net income 2024 835M 10M Net income 2025 * 1.12B 13.39M EV / Sales 2024 2.69 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.92 x
P/E ratio 2024
30.8 x
P/E ratio 2025 *
27.7 x
Employees -
Yield 2024
0.5%
Yield 2025 *
0.73%
Free-Float 24.02%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.95%
1 week-7.49%
Current month+7.35%
1 month+2.75%
3 months+3.69%
6 months-4.69%
Current year-4.72%
More quotes
1 week
283.40
Extreme 283.4
325.00
1 month
262.20
Extreme 262.2
325.00
Current year
212.05
Extreme 212.05
333.85
1 year
180.35
Extreme 180.35
333.85
3 years
95.10
Extreme 95.1
333.85
5 years
40.05
Extreme 40.05
333.85
10 years
40.05
Extreme 40.05
333.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 94-02-28
Director of Finance/CFO 44 23-05-18
Chief Operating Officer - 07-04-05
Members of the board TitleAgeSince
Director/Board Member 63 22-10-17
Director/Board Member 49 10-05-31
Chief Executive Officer 61 94-02-28
More insiders
Date Price Change Volume
24-07-12 287.7 -2.95% 13,739
24-07-11 296.4 +4.02% 44,270
24-07-10 285 -3.18% 41,341
24-07-09 294.4 -0.83% 45,302
24-07-08 296.8 -4.57% 240,305

Delayed Quote Bombay S.E., July 12, 2024 at 06:00 am EDT

More quotes
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company operate through three main verticals: hospital business, Shalby Orthopedics Centre of Excellence (SOCE) franchise and implant business. The Company is engaged in the arthroplasty segment. It has its presence across tertiary and quaternary specialties including cardiology, neurology, oncology and cardiac. SOCE offers a comprehensive orthopedic center with easy access and treatment for all orthopedic-related issues, including joint replacement surgery, at affordable rates. The Company encompasses a range of specialties, which include joint replacement surgery, critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, medical oncology and once-surgery, dental cosmetics and implantology, ophthalmology, plastic and more.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
287.9 INR
Average target price
320 INR
Spread / Average Target
+11.15%
Consensus

Quarterly revenue - Rate of surprise